Thomas Bonnefont

Chief Operating Officer & Chief Commercial Officer at Median Technologies - Ibiopsy @Median Technologies

Global role of management & development of iBiopsy® non-invasive image-based diagnosis tests primarily for oncology & related diseases such as Lung Cancer, Liver Cancer (HCC), Liver disease (NASH), as well as immuno-oncology drugs efficacy prediction for an earlier diagnosis and better patient outcome in the context of precision medicine. Based on the most advanced technologies in Artificial Intelligence benefiting from Median Technologies’ expertise in Data Science & Medical Imaging processing.